======= FBXL14 ======= == Gene Information == * **Official Symbol**: FBXL14 * **Official Name**: F-box and leucine rich repeat protein 14 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=144699|144699]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N1E6|Q8N1E6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FBXL14&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FBXL14|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609081|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Substrate-recognition component of some SCF (SKP1-CUL1- F-box protein)-type E3 ubiquitin-protein ligase complexes. The SCF(FBXL14) complex acts by mediating ubiquitination and subsequent degradation of SNAI1. {ECO:0000269|PubMed:19955572}. |F-box-like| |SCF ubiquitin ligase complex| |SCF-dependent proteasomal ubiquitin-dependent protein catabolic process| |ubiquitin-protein transferase activity| |protein polyubiquitination| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |post-translational protein modification| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |protein modification by small protein conjugation| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp33|Rotenone 2μM R00 exp33]]|-2.15| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.94| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.8| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.77| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.76| |[[:results:exp287|HMS-I2 5μM R06 exp287]]|1.81| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12773 * **Expression level (log2 read counts)**: 3.48 {{:chemogenomics:nalm6 dist.png?nolink |}}